ArticleActa pharmacologica Sinica2019

Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway.

Xue-Mei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.